Open main menu

Pages with the most revisions

Showing below up to 250 results in range #501 to #750.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Allometry‏‎ (1 revision)
  2. ICRP Publication 92‏‎ (1 revision)
  3. ICRP Publication 102‏‎ (1 revision)
  4. Informed consent‏‎ (1 revision)
  5. ICRP Publication 116‏‎ (1 revision)
  6. Spongiosa‏‎ (1 revision)
  7. ICRP Publication 130‏‎ (1 revision)
  8. ICRP Publication 145‏‎ (1 revision)
  9. Marrow cellularity‏‎ (1 revision)
  10. ICRP Publication 2‏‎ (1 revision)
  11. Multitarget equation‏‎ (1 revision)
  12. ICRP Publication 30 (Part 3)‏‎ (1 revision)
  13. Derived consideration reference level‏‎ (1 revision)
  14. ICRP Publication 40‏‎ (1 revision)
  15. ICRP Publication 55‏‎ (1 revision)
  16. Dose conversion convention‏‎ (1 revision)
  17. Pilomatricoma‏‎ (1 revision)
  18. ICRP Publication 7‏‎ (1 revision)
  19. ICRP Publication 84‏‎ (1 revision)
  20. Radiation-induced secondary malignancy‏‎ (1 revision)
  21. Exclusion‏‎ (1 revision)
  22. Radiological attack‏‎ (1 revision)
  23. Referrer‏‎ (1 revision)
  24. ICRP Publication 93‏‎ (1 revision)
  25. ICRU 4-element tissue‏‎ (1 revision)
  26. Biological half-life‏‎ (1 revision)
  27. ICRP Publication 117‏‎ (1 revision)
  28. ICRP Publication 131‏‎ (1 revision)
  29. System of radiological protection‏‎ (1 revision)
  30. ICRP Publication 146‏‎ (1 revision)
  31. Concentration ratio‏‎ (1 revision)
  32. Time-resolved computed tomography‏‎ (1 revision)
  33. ICRP Publication 20‏‎ (1 revision)
  34. Mutation component‏‎ (1 revision)
  35. ICRP Publication 30 (Part 4)‏‎ (1 revision)
  36. Derived investigation level‏‎ (1 revision)
  37. Waste management‏‎ (1 revision)
  38. Normal tissue complication probability‏‎ (1 revision)
  39. ICRP Publication 41‏‎ (1 revision)
  40. Directional dose equivalent‏‎ (1 revision)
  41. ICRP Publication 56‏‎ (1 revision)
  42. Dose conversion factor‏‎ (1 revision)
  43. ICRP Publication 70‏‎ (1 revision)
  44. Effect modifier‏‎ (1 revision)
  45. ICRP Publication 85‏‎ (1 revision)
  46. Endosteum‏‎ (1 revision)
  47. Radiological controlled area‏‎ (1 revision)
  48. Region‏‎ (1 revision)
  49. ICRP Publication 94‏‎ (1 revision)
  50. Human Alimentary Tract Model‏‎ (1 revision)
  51. ICRU sphere‏‎ (1 revision)
  52. ICRP Publication 104‏‎ (1 revision)
  53. Biomarker‏‎ (1 revision)
  54. ICRP Publication 132‏‎ (1 revision)
  55. Clonogenic surviving fraction‏‎ (1 revision)
  56. ICRP Publication 147‏‎ (1 revision)
  57. Cone beam computed tomography‏‎ (1 revision)
  58. ICRP Publication 21‏‎ (1 revision)
  59. Treatment preparation in radiotherapy‏‎ (1 revision)
  60. ICRP Publication 30 (Supplement A to Part 3)‏‎ (1 revision)
  61. Derived limit‏‎ (1 revision)
  62. Notification value‏‎ (1 revision)
  63. ICRP Publication 42‏‎ (1 revision)
  64. Other (systemic) tissues‏‎ (1 revision)
  65. ICRP Publication 57‏‎ (1 revision)
  66. ICRP Publication 71‏‎ (1 revision)
  67. ICRP Publication 86‏‎ (1 revision)
  68. Absorption Type‏‎ (1 revision - redirect page)
  69. Additional dose‏‎ (1 revision)
  70. Regional diagnostic reference levels‏‎ (1 revision)
  71. Ambient dose equivalent‏‎ (1 revision)
  72. ICRP Publication 95‏‎ (1 revision)
  73. Human Respiratory Tract Model‏‎ (1 revision)
  74. Automatic exposure control‏‎ (1 revision)
  75. Sealed source‏‎ (1 revision)
  76. ICRP Publication 105‏‎ (1 revision)
  77. Solar flare‏‎ (1 revision)
  78. ICRP Publication 119‏‎ (1 revision)
  79. ICRP Publication 133‏‎ (1 revision)
  80. Linear dose response‏‎ (1 revision)
  81. ICRP Publication 148‏‎ (1 revision)
  82. Mean glandular dose‏‎ (1 revision)
  83. ICRP Publication 22‏‎ (1 revision)
  84. Trophic level‏‎ (1 revision)
  85. ICRP Publication 30 (Supplement B to Part 3)‏‎ (1 revision)
  86. Derived reference level‏‎ (1 revision)
  87. Nuclear medicine‏‎ (1 revision)
  88. ICRP Publication 43‏‎ (1 revision)
  89. Disposal facility‏‎ (1 revision)
  90. ICRP Publication 58‏‎ (1 revision)
  91. Pooled analysis‏‎ (1 revision)
  92. ICRP Publication 72‏‎ (1 revision)
  93. ICRP Publication 87‏‎ (1 revision)
  94. Radiation risk‏‎ (1 revision)
  95. Additive risk projection model‏‎ (1 revision)
  96. Registry‏‎ (1 revision)
  97. ICRP Publication 96‏‎ (1 revision)
  98. Secondary radiation‏‎ (1 revision)
  99. ICRP Publication 106‏‎ (1 revision)
  100. Intake‏‎ (1 revision)
  101. ICRP Publication 12‏‎ (1 revision)
  102. Standard-size adult‏‎ (1 revision)
  103. ICRP Publication 134‏‎ (1 revision)
  104. Cobblestone area forming cell assay‏‎ (1 revision)
  105. ICRP Publication 149‏‎ (1 revision)
  106. Tissue reaction‏‎ (1 revision)
  107. Measured quantity‏‎ (1 revision)
  108. ICRP Publication 23‏‎ (1 revision)
  109. DRL quantity‏‎ (1 revision)
  110. Tumour suppressor gene‏‎ (1 revision)
  111. National DRL‏‎ (1 revision)
  112. ICRP Publication 30 (Supplement to Part 1)‏‎ (1 revision)
  113. Designated area‏‎ (1 revision)
  114. ICRP Publication 44‏‎ (1 revision)
  115. Distribution coefficient‏‎ (1 revision)
  116. Oxygen enhancement ratio‏‎ (1 revision)
  117. ICRP Publication 59‏‎ (1 revision)
  118. Population risk‏‎ (1 revision)
  119. ICRP Publication 73‏‎ (1 revision)
  120. ICRP Publication 88‏‎ (1 revision)
  121. Epigenetic effects‏‎ (1 revision)
  122. 1928 Recommendations‏‎ (1 revision)
  123. Redox‏‎ (1 revision)
  124. Adenoma‏‎ (1 revision)
  125. ICRP Publication 97‏‎ (1 revision)
  126. Secretory cells‏‎ (1 revision)
  127. ICRP Publication 107‏‎ (1 revision)
  128. Intensity-modulated radiotherapy‏‎ (1 revision)
  129. ICRP Publication 120‏‎ (1 revision)
  130. Carers and comforters‏‎ (1 revision)
  131. Stem cell‏‎ (1 revision)
  132. Kerma approximation‏‎ (1 revision)
  133. ICRP Publication 135‏‎ (1 revision)
  134. ICRP Publication 15‏‎ (1 revision)
  135. ICRP Publication 24‏‎ (1 revision)
  136. National radon survey‏‎ (1 revision)
  137. ICRP Publication 30 (Supplement to Part 2)‏‎ (1 revision)
  138. Detector quantum efficiency‏‎ (1 revision)
  139. ICRP Publication 45‏‎ (1 revision)
  140. ICRP Publication 6‏‎ (1 revision)
  141. Potential alpha energy concentration‏‎ (1 revision)
  142. ICRP Publication 74‏‎ (1 revision)
  143. ICRP Publication 89‏‎ (1 revision)
  144. Exogenous excretion‏‎ (1 revision)
  145. 1931 Recommendations‏‎ (1 revision)
  146. Access control‏‎ (1 revision)
  147. General Information: Radon‏‎ (1 revision - redirect page)
  148. Relative biological effectiveness‏‎ (1 revision)
  149. ICRP Publication 98‏‎ (1 revision)
  150. ICRP Publication 108‏‎ (1 revision)
  151. Brachytherapy‏‎ (1 revision)
  152. Somatic effect‏‎ (1 revision)
  153. ICRP Publication 121‏‎ (1 revision)
  154. Case–control study‏‎ (1 revision)
  155. ICRP Publication 136‏‎ (1 revision)
  156. Collective dose‏‎ (1 revision)
  157. Targeted effects‏‎ (1 revision)
  158. ICRP Publication 150‏‎ (1 revision)
  159. ICRP Publication 25‏‎ (1 revision)
  160. Typical value‏‎ (1 revision)
  161. ICRP Publication 31‏‎ (1 revision)
  162. Deterministic effect‏‎ (1 revision)
  163. ICRP Publication 46‏‎ (1 revision)
  164. Particle transport‏‎ (1 revision)
  165. ICRP Publication 60‏‎ (1 revision)
  166. Dose modifying factor‏‎ (1 revision)
  167. ICRP Publication 75‏‎ (1 revision)
  168. ICRP Publication 9‏‎ (1 revision)
  169. 1934 Recommendations‏‎ (1 revision)
  170. 1937 Recommendations‏‎ (1 revision)
  171. Radon-prone area‏‎ (1 revision)
  172. Reference Person‏‎ (1 revision)
  173. Adventitious source‏‎ (1 revision)
  174. Relative life lost‏‎ (1 revision)
  175. Annual intake‏‎ (1 revision)
  176. ICRP Publication 99‏‎ (1 revision)
  177. Security screening‏‎ (1 revision)
  178. ICRP Publication 109‏‎ (1 revision)
  179. ICRP Publication 122‏‎ (1 revision)
  180. Stochastic effect‏‎ (1 revision)
  181. ICRP Publication 137‏‎ (1 revision)
  182. ICRP Publication 151‏‎ (1 revision)
  183. Tolerance dose‏‎ (1 revision)
  184. ICRP Publication 26‏‎ (1 revision)
  185. DS86‏‎ (1 revision)
  186. ICRP Publication 32‏‎ (1 revision)
  187. Occupancy factor‏‎ (1 revision)
  188. ICRP Publication 47‏‎ (1 revision)
  189. ICRP Publication 61‏‎ (1 revision)
  190. ICRP Publication 76‏‎ (1 revision)
  191. Equilibrium equivalent concentration‏‎ (1 revision)
  192. Expanded radiation field‏‎ (1 revision)
  193. 1950 Recommendations‏‎ (1 revision)
  194. Relative risk‏‎ (1 revision)
  195. Ring chromosome‏‎ (1 revision)
  196. ICRP Supporting Guidance 2‏‎ (1 revision)
  197. Backscatter factor‏‎ (1 revision)
  198. ICRP Publication 10A‏‎ (1 revision)
  199. International Commission on Radiological Protection‏‎ (1 revision)
  200. ICRP Publication 123‏‎ (1 revision)
  201. Charged-particle equilibrium‏‎ (1 revision)
  202. Lag‏‎ (1 revision)
  203. ICRP Publication 138‏‎ (1 revision)
  204. Collimation‏‎ (1 revision)
  205. Teratocarcinoma‏‎ (1 revision)
  206. Low dose‏‎ (1 revision)
  207. ICRP Publication 152‏‎ (1 revision)
  208. ICRP Publication 27‏‎ (1 revision)
  209. ICRP Publication 33‏‎ (1 revision)
  210. Detriment-adjusted risk‏‎ (1 revision)
  211. ICRP Publication 48‏‎ (1 revision)
  212. Dose-response function‏‎ (1 revision)
  213. ICRP Publication 62‏‎ (1 revision)
  214. Potentially lethal damage repair‏‎ (1 revision)
  215. ICRP Publication 77‏‎ (1 revision)
  216. Equilibrium factor‏‎ (1 revision)
  217. Exposed individuals‏‎ (1 revision)
  218. 1954 Recommendations‏‎ (1 revision)
  219. Relative survival‏‎ (1 revision)
  220. Apoptosis‏‎ (1 revision)
  221. ICRP Publication 11‏‎ (1 revision)
  222. Source region‏‎ (1 revision)
  223. ICRP Publication 124‏‎ (1 revision)
  224. Late normal tissue responses‏‎ (1 revision)
  225. ICRP Publication 139‏‎ (1 revision)
  226. ICRP Publication 153‏‎ (1 revision)
  227. ICRP Publication 28‏‎ (1 revision)
  228. ICRP Publication 34‏‎ (1 revision)
  229. Α/β value‏‎ (1 revision)
  230. Oncogene‏‎ (1 revision)
  231. ICRP Publication 49‏‎ (1 revision)
  232. ICRP Publication 63‏‎ (1 revision)
  233. ICRP Publication 78‏‎ (1 revision)
  234. Elemental dose‏‎ (1 revision)
  235. 1956 Recommendations‏‎ (1 revision)
  236. Activation‏‎ (1 revision)
  237. ICRP Publication 1‏‎ (1 revision)
  238. Baseline disease rates‏‎ (1 revision)
  239. Severe deterministic injury‏‎ (1 revision)
  240. ICRP Publication 110‏‎ (1 revision)
  241. Breakpoint cluster region/abelson‏‎ (1 revision)
  242. Intervention‏‎ (1 revision)
  243. ICRP Publication 125‏‎ (1 revision)
  244. Sublethal damage repair‏‎ (1 revision)
  245. ICRP Publication 14‏‎ (1 revision)
  246. Commissioning‏‎ (1 revision)
  247. ICRP Publication 154‏‎ (1 revision)
  248. Cosmic radiation‏‎ (1 revision)
  249. Transfer of risk‏‎ (1 revision)
  250. Molecular imaging‏‎ (1 revision)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)